Association of signaling transducers and activators of transcription 1 and systemic lupus erythematosus

Abstract Systemic lupus erythematosus (SLE) is complex autoimmune disease which involves various facets of the immune system. Signaling transducers and activators of transcription 1 (STAT1) belongs to the family of STAT transcription factors that mediate various biological responses. Recently, studies in both experimental animal models of lupus and patients with SLE have revealed expression and activation of STAT1 is closely associated with the pathogenesis of SLE. Moreover, increased production of interferons (IFNs) and aberrant activation of IFNs signaling, which is mechanistically linked to increased level of STAT1, are crucial for the development of SLE. Therefore, we will focus on the association of STAT1 and SLE based on recent understandings to render more information about the mechanisms of STAT1 might perform in. Hopefully, the information obtained will lead to a better understanding of the development and pathogenesis of systemic autoimmune diseases, as well as its clinical implications and therapeutic potential.

[1]  Lang Li,et al.  Endothelial microparticles exert differential effects on functions of Th1 in patients with acute coronary syndrome. , 2013, International journal of cardiology.

[2]  Han Yang,et al.  Ubiquitin-Specific Protease 13 Regulates IFN Signaling by Stabilizing STAT1 , 2013, The Journal of Immunology.

[3]  J. Wren,et al.  Genome-wide DNA methylation study suggests epigenetic accessibility and transcriptional poising of interferon-regulated genes in naïve CD4+ T cells from lupus patients. , 2013, Journal of autoimmunity.

[4]  M. Cancro,et al.  The role of B lymphocyte stimulator in B cell biology: implications for the treatment of lupus , 2013, Lupus.

[5]  M. Diaz.  The role of activation-induced deaminase in Lupus Nephritis , 2013, Autoimmunity.

[6]  C. Tung,et al.  Decreased microRNA(miR)‐145 and increased miR‐224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis , 2013, Clinical and experimental immunology.

[7]  L. Ivashkiv,et al.  The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment. , 2012, Arthritis and rheumatism.

[8]  I. Bekeredjian-Ding,et al.  Plasmacytoid dendritic cells control B cell-derived IL-10 production , 2012, Autoimmunity.

[9]  J. Casanova,et al.  Inborn errors of human STAT1: allelic heterogeneity governs the diversity of immunological and infectious phenotypes , 2012, Current Opinion in Immunology.

[10]  I. Campbell,et al.  Mice Deficient in STAT1 but Not STAT2 or IRF9 Develop a Lethal CD4+ T-Cell-Mediated Disease following Infection with Lymphocytic Choriomeningitis Virus , 2012, Journal of Virology.

[11]  M. Brinton,et al.  Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation. , 2012, Virology.

[12]  M. Aringer,et al.  Interferon signals and monocytic sensitization of the interferon-γ signaling pathway in the peripheral blood of patients with rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[13]  D. Choubey,et al.  Distinct Regulation of Murine Lupus Susceptibility Genes by the IRF5/Blimp-1 Axis , 2012, The Journal of Immunology.

[14]  J. Chuang,et al.  Melatonin attenuates brain contusion‐induced oxidative insult, inactivation of signal transducers and activators of transcription 1, and upregulation of suppressor of cytokine signaling‐3 in rats , 2011, Journal of pineal research.

[15]  M. Akahoshi,et al.  Th Subset Balance in Lupus Nephritis , 2011, Journal of biomedicine & biotechnology.

[16]  C. Bao,et al.  Multidimensional Single Cell Based STAT Phosphorylation Profiling Identifies a Novel Biosignature for Evaluation of Systemic Lupus Erythematosus Activity , 2011, PloS one.

[17]  M. Radic,et al.  Regulatory and pathogenetic mechanisms of autoantibodies in SLE , 2011, Autoimmunity.

[18]  D. Choubey,et al.  Aim2 Deficiency in Mice Suppresses the Expression of the Inhibitory Fcγ Receptor (FcγRIIB) through the Induction of the IFN-Inducible p202, a Lupus Susceptibility Protein , 2011, The Journal of Immunology.

[19]  Riitta Lahesmaa,et al.  Genomic views of STAT function in CD4+ T helper cell differentiation , 2011, Nature Reviews Immunology.

[20]  A. Syvänen,et al.  A candidate gene study of the type I interferon pathway implicates IKBKE and IL8 as risk loci for SLE , 2010, European Journal of Human Genetics.

[21]  D. Choubey,et al.  Aim2 Deficiency Stimulates the Expression of IFN-Inducible Ifi202, a Lupus Susceptibility Murine Gene within the Nba2 Autoimmune Susceptibility Locus , 2010, The Journal of Immunology.

[22]  O. Crasta,et al.  Identification of a Common Lupus Disease-Associated microRNA Expression Pattern in Three Different Murine Models of Lupus , 2010, PloS one.

[23]  S. Lapter,et al.  A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 mice. , 2009, Clinical immunology.

[24]  S. Klaschik,et al.  Therapeutic Applications and Mechanisms Underlying the Activity of Immunosuppressive Oligonucleotides , 2009, Annals of the New York Academy of Sciences.

[25]  Peter O. Krutzik,et al.  Stage Dependent Aberrant Regulation of Cytokine-STAT Signaling in Murine Systemic Lupus Erythematosus , 2009, PloS one.

[26]  M. Aringer,et al.  Activation of the interferon-gamma signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. , 2009, Arthritis and rheumatism.

[27]  P. Tak,et al.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins. , 2009, Arthritis and rheumatism.

[28]  Don L. Armstrong,et al.  High-density genotyping of STAT4 reveals multiple haplotypic associations with systemic lupus erythematosus in different racial groups. , 2009, Arthritis and rheumatism.

[29]  I. Bekeredjian-Ding,et al.  PDC expressing CD36, CD61 and IL-10 may contribute to propagation of immune tolerance , 2009, Autoimmunity.

[30]  N. Eriksson,et al.  STAT4 associates with systemic lupus erythematosus through two independent effects that correlate with gene expression and act additively with IRF5 to increase risk , 2008, Annals of the rheumatic diseases.

[31]  F. Belardelli,et al.  IFN-alpha in the generation of dendritic cells for cancer immunotherapy. , 2009, Handbook of experimental pharmacology.

[32]  Xiaoyu Hu,et al.  Regulation of interferon and Toll‐like receptor signaling during macrophage activation by opposing feedforward and feedback inhibition mechanisms , 2008, Immunological reviews.

[33]  Courtney R. Plumlee,et al.  Inteferons pen the JAK-STAT pathway. , 2008, Seminars in cell & developmental biology.

[34]  M. Labrador-Horrillo,et al.  Activation of the signal transducer and activator of transcription-1 in diffuse proliferative lupus nephritis , 2007, Lupus.

[35]  F. Houssiau,et al.  Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus. , 2007, Arthritis and rheumatism.

[36]  Myung-Shik Lee,et al.  STAT1 as a key modulator of cell death. , 2007, Cellular signalling.

[37]  Y. Zhang,et al.  Activation of the STAT1 signalling pathway in lupus nephritis in MRL/lpr mice , 2007, Lupus.

[38]  G. Tsokos,et al.  Increased expression of STAT3 in SLE T cells contributes to enhanced chemokine-mediated cell migration , 2007, Autoimmunity.

[39]  R. Fujinami,et al.  Multiple sclerosis and virus induced immune responses: Autoimmunity can be primed by molecular mimicry and augmented by bystander activation , 2006, Autoimmunity.

[40]  P. Petrow,et al.  Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1) , 2005, Arthritis research & therapy.

[41]  M. Chelbi-alix,et al.  An essential role for IFN-alpha in the overexpression of Fas ligand on MRL/lpr lymphocytes and on their spontaneous Fas-mediated cytotoxic potential. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[42]  Y. Shima,et al.  Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. , 2004, International immunology.

[43]  L. Ivashkiv.  Type I Interferon Modulation of Cellular Responses to Cytokines and Infectious Pathogens: Potential Role in SLE Pathogenesis , 2003, Autoimmunity.

[44]  G. Illei,et al.  Monocyte response to Th1 stimulation and effector function toward human mesangial cells are not impaired in patients with lupus nephritis. , 2003, Clinical immunology.

[45]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[46]  K. Ihara,et al.  A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. , 2002, The Journal of rheumatology.

[47]  D. Frank,et al.  The role of STATs in apoptosis. , 2002, Current molecular medicine.

[48]  T. Saruta,et al.  Balance of GAD65-Specific IL-10 Production and Polyclonal Thl-Type Response in Type 1 Diabetes , 2001, Autoimmunity.